Transactivation of ErbB-2 induced by tumor necrosis factor α promotes NF-κB activation and breast cancer cell proliferation

Breast Cancer Research and Treatment

Volumn 122, Issue 1, 2010, Pages 111-124

  Rivas, Martín A ^a   Tkach, Mercedes ^a   Beguelin, Wendy ^a   Proietti, Cecilia J ^a   Rosemblit, Cinthia ^a   Charreau, Eduardo H ^a   Elizalde, Patricia V ^a   Schillaci, Roxana ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

C Src; ErbB 2; Herceptin; TNF

Indexed keywords

5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROGESTERONE RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; TRASTUZUMAB; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; ERBB2 PROTEIN, HUMAN; ERBB2 PROTEIN, MOUSE; PROTEIN KINASE; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INFILTRATION; CANCER INHIBITION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TUMOR MICROENVIRONMENT; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BREAST TUMOR; CELL DIVISION; DIMERIZATION; DRUG EFFECTS; EXPERIMENTAL MAMMARY NEOPLASM; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; PROTO ONCOGENE; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; DIMERIZATION; FEMALE; GENES, ERBB-2; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, ERBB-2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953542711     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0546-3     Document Type: Article

References (43)

1. EA Carswell LJ Old RL Kassel S Green N Fiore B Williamson 1975 An endotoxin-induced serum factor that causes necrosis of tumors Proc Natl Acad Sci USA 72 3666 3670 10.1073/pnas.72.9.3666 1:STN:280:DyaE28%2FltlWrtg%3D%3D 1103152
2. S Wu CM Boyer RS Whitaker A Berchuck JR Wiener JB Weinberg RC Bast Jr 1993 Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression Cancer Res 53 1939 1944 1:CAS:528: DyaK3sXisFeitr0%3D 8385577
3. MS Naylor GW Stamp WD Foulkes D Eccles FR Balkwill 1993 Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression J Clin Invest 91 2194 2206 10.1172/JCI116446 1:STN:280: DyaK3s3ltlSltQ%3D%3D 8387543
4. MF Rubio S Werbajh EG Cafferata A Quaglino GP Colo IM Nojek EC Kordon VE Nahmod MA Costas 2006 TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B Oncogene 25 1367 1377 10.1038/sj.onc.1209176 1:CAS:528: DC%2BD28XhvFais7o%3D 16331275 (Pubitemid 43336465)
5. MA Rivas RP Carnevale CJ Proietti C Rosemblit W Beguelin M Salatino EH Charreau I Frahm S Sapia P Brouckaert PV Elizalde R Schillaci 2008 TNFalpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappaB-dependent pathways Exp Cell Res 314 509 529 10.1016/j.yexcr.2007.10. 005 1:CAS:528:DC%2BD1cXpsFOqsQ%3D%3D 18061162
6. I Garcia-Tunon M Ricote A Ruiz B Fraile R Paniagua M Royuela 2006 Role of tumor necrosis factor-alpha and its receptors in human benign breast lesions and tumors (in situ and infiltrative) Cancer Sci 97 1044 1049 10.1111/j.1349-7006.2006.00277.x 1:CAS:528:DC%2BD28XhtVyltrjP 16984377 (Pubitemid 44322552)
7. G Pirianov KW Colston 2001 Interactions of vitamin D analogue CB1093, TNFalpha and ceramide on breast cancer cell apoptosis Mol Cell Endocrinol 172 69 78 10.1016/S0303-7207(00)00380-4 1:CAS:528:DC%2BD3MXnsVakuw%3D%3D 11165041 (Pubitemid 32098401)
8. MA Lyu MG Rosenblum 2005 The immunocytokine scFv23/TNF sensitizes HER-2/neu-overexpressing SKBR-3 cells to tumor necrosis factor (TNF) via up-regulation of TNF receptor-1 Mol Cancer Ther 4 1205 1213 10.1158/1535-7163. MCT-05-0014 1:CAS:528:DC%2BD2MXnt1ShtLs%3D 16093436 (Pubitemid 41149568)
9. DJ Slamon GM Clark SG Wong WJ Levin A Ullrich WL McGuire 1987 Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 177 182 10.1126/science.3798106 1:CAS:528:DyaL2sXhtVSht7s%3D 3798106
10. BP Zhou MC Hu SA Miller Z Yu W Xia SY Lin MC Hung 2000 HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway J Biol Chem 275 8027 8031 10.1074/jbc.275.11.8027 1:CAS:528:DC%2BD3cXitVyltL8%3D 10713122 (Pubitemid 30159714)
11. Y Yarden MX Sliwkowski 2001 Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 127 137 10.1038/35052073 1:CAS:528:DC%2BD3MXivVWnt7k%3D 11252954 (Pubitemid 33674041)
12. E Tzahar H Waterman X Chen G Levkowitz D Karunagaran S Lavi BJ Ratzkin Y Yarden 1996 A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor Mol Cell Biol 16 5276 5287 1:CAS:528:DyaK28XlvFamt70%3D 8816440
13. P Carter L Presta CM Gorman JB Ridgway D Henner WL Wong AM Rowland C Kotts ME Carver HM Shepard 1992 Humanization of an anti-p185HER2 antibody for human cancer therapy Proc Natl Acad Sci USA 89 4285 4289 10.1073/pnas.89.10.4285 1:CAS:528:DyaK3sXitFSqtb0%3D 1350088
14. NE Hynes HA Lane 2005 ERBB receptors and cancer: the complexity of targeted inhibitors Nat Rev Cancer 5 341 354 10.1038/nrc1609 1:CAS:528:DC%2BD2MXjslertb0%3D 15864276 (Pubitemid 40637826)
15. N Cabioglu J Summy C Miller NU Parikh AA Sahin S Tuzlali K Pumiglia GE Gallick JE Price 2005 CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation Cancer Res 65 6493 6497 10.1158/0008-5472.CAN-04-1303 1:CAS:528:DC%2BD2MXmvFSlsbw%3D 16061624 (Pubitemid 41060680)
16. T Yamauchi N Yamauchi K Ueki T Sugiyama H Waki H Miki K Tobe S Matsuda T Tsushima T Yamamoto T Fujita Y Taketani M Fukayama S Kimura Y Yazaki R Nagai T Kadowaki 2000 Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer J Biol Chem 275 33937 33944 10.1074/jbc.M000743200 1:CAS:528:DC%2BD3cXnvVyjtLs%3D 10938266
17. Y Qiu L Ravi HJ Kung 1998 Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells Nature 393 83 85 10.1038/30012 1:CAS:528:DyaK1cXjt1amu7s%3D 9590694 (Pubitemid 28240259)
18. CW Lee CC Lin WN Lin KC Liang SF Luo CB Wu SW Wang CM Yang 2007 TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells Am J Physiol Lung Cell Mol Physiol 292 L799 L812 10.1152/ajplung.00311.2006 1:CAS:528:DC%2BD2sXjsFCjsLs%3D 17158602 (Pubitemid 46376998)
19. M Chokki H Mitsuhashi T Kamimura 2006 Metalloprotease-dependent amphiregulin release mediates tumor necrosis factor-alpha-induced IL-8 secretion in the human airway epithelial cell line NCI-H292 Life Sci 78 3051 3057 10.1016/j.lfs.2005.12.023 1:CAS:528:DC%2BD28XksVagsb8%3D 16427093
20. WN Chen RL Woodbury LE Kathmann LK Opresko RC Zangar HS Wiley BD Thrall 2004 Induced autocrine signaling through the epidermal growth factor receptor contributes to the response of mammary epithelial cells to tumor necrosis factor alpha J Biol Chem 279 18488 18496 10.1074/jbc.M310874200 1:CAS:528: DC%2BD2cXjsVKnu70%3D 14978035 (Pubitemid 38623267)
21. ME Balana L Labriola M Salatino F Movsichoff G Peters EH Charreau PV Elizalde 2001 Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells Oncogene 20 34 47 10.1038/sj.onc.1204050 1:CAS:528:DC%2BD3MXhtFChsbs%3D 11244498 (Pubitemid 32142336)
22. L Labriola M Salatino CJ Proietti A Pecci OA Coso AR Kornblihtt EH Charreau PV Elizalde 2003 Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells Mol Cell Biol 23 1095 1111 10.1128/MCB.23.3.1095-1111.2003 1:CAS:528:DC%2BD3sXnvFGntQ%3D%3D 12529413 (Pubitemid 36133525)
23. C Lanari E Kordon A Molinolo CD Pasqualini EH Charreau 1989 Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines Int J Cancer 43 845 850 10.1002/ijc.2910430518 1:CAS:528:DyaL1MXktlCqur8%3D 2523869 (Pubitemid 19138192)
24. ME Balana R Lupu L Labriola EH Charreau PV Elizalde 1999 Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas Oncogene 18 6370 6379 10.1038/sj.onc.1203028 1:CAS:528:DyaK1MXnslKrt7w%3D 10597237
25. M Salatino W Beguelin MG Peters R Carnevale CJ Proietti MD Galigniana CG Vedoy R Schillaci EH Charreau MC Sogayar PV Elizalde 2006 Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation Oncogene 25 7723 7739 10.1038/sj.onc.1209757 1:CAS:528:DC%2BD28XhtlSqurjM 16799639 (Pubitemid 44967967)
26. GD Plowman JM Culouscou GS Whitney JM Green GW Carlton L Foy MG Neubauer M Shoyab 1993 Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family Proc Natl Acad Sci USA 90 1746 1750 10.1073/pnas.90.5.1746 1:CAS:528:DyaK3sXisVOrtrk%3D 8383326
27. G Brockhoff P Heiss J Schlegel F Hofstaedter R Knuechel 2001 Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells Cytometry 44 338 348 10.1002/1097-0320(20010801)44:4<338::AID-CYTO1125>3.0.CO;2-V 1:CAS:528:DC%2BD3MXmsFOgsLo%3D 11500850
28. W Xu X Yuan K Beebe Z Xiang L Neckers 2007 Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity Mol Cell Biol 27 220 228 10.1128/MCB.00899-06 1:CAS:528:DC%2BD2sXjs1Ol 17030621 (Pubitemid 46013246)
29. RC Ishizawar T Miyake SJ Parsons 2007 c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function Oncogene 26 3503 3510 10.1038/sj.onc. 1210138 1:CAS:528:DC%2BD2sXls1Gqt7g%3D 17173075 (Pubitemid 46816756)
30. WC Huang JJ Chen H Inoue CC Chen 2003 Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression J Immunol 170 4767 4775 1:CAS:528:DC%2BD3sXjtVKntb4%3D 12707358
31. T Holbro RR Beerli F Maurer M Koziczak CF Barbas III NE Hynes 2003 The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation Proc Natl Acad Sci USA 100 8933 8938 10.1073/pnas.1537685100 1:CAS:528:DC%2BD3sXlvVyitbY%3D 12853564 (Pubitemid 36899201)
32. M Hinz D Krappmann A Eichten A Heder C Scheidereit M Strauss 1999 NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition Mol Cell Biol 19 2690 2698 1:CAS:528: DyaK1MXit1amt7s%3D 10082535
33. H Kim R Chan DL Dankort D Zuo M Najoukas M Park WJ Muller 2005 The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation Oncogene 24 7599 7607 10.1038/sj.onc.1208898 1:CAS:528:DC%2BD2MXht1Wktr%2FJ 16170374 (Pubitemid 41638034)
34. AP Belsches-Jablonski JS Biscardi DR Peavy DA Tice DA Romney SJ Parsons 2001 Src family kinases and HER2 interactions in human breast cancer cell growth and survival Oncogene 20 1465 1475 10.1038/sj.onc.1204205 1:CAS:528: DC%2BD3MXis1Klsbc%3D 11313890 (Pubitemid 32291197)
35. R Pincheira AF Castro ON Ozes PS Idumalla DB Donner 2008 Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity J Immunol 181 1288 1298 1:CAS:528:DC%2BD1cXotF2rtr0%3D 18606683
36. T Yamaoka F Yan H Cao SS Hobbs RS Dise W Tong DB Polk 2008 Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis Proc Natl Acad Sci USA 105 11772 11777 10.1073/pnas.0801463105 1:CAS:528:DC%2BD1cXhtVCnurrN 18701712
37. RM Hudziak GD Lewis MR Shalaby TE Eessalu BB Aggarwal A Ullrich HM Shepard 1988 Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells Proc Natl Acad Sci USA 85 5102 5106 10.1073/pnas.85.14.5102 1:CAS:528:DyaL1cXlt1KltL0%3D 2899323
38. DK Biswas Q Shi S Baily I Strickland S Ghosh AB Pardee JD Iglehart 2004 NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis Proc Natl Acad Sci USA 101 10137 10142 10.1073/pnas.0403621101 1:CAS:528:DC%2BD2cXlvFOhsL4%3D 15220474 (Pubitemid 38891208)
39. S Singh Q Shi ST Bailey MJ Palczewski AB Pardee JD Iglehart DK Biswas 2007 Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer Mol Cancer Ther 6 1973 1982 10.1158/1535-7163.MCT-07-0063 1:CAS:528:DC%2BD2sXnsV2jsr0%3D 17620428 (Pubitemid 47052487)
40. CL Vogel MA Cobleigh D Tripathy JC Gutheil LN Harris L Fehrenbacher DJ Slamon M Murphy WF Novotny M Burchmore S Shak SJ Stewart M Press 2002 Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer J Clin Oncol 20 719 726 10.1200/JCO.20.3.719 1:CAS:528:DC%2BD38XhsVGmt7o%3D 11821453 (Pubitemid 34111379)
41. CA Ritter M Perez-Torres C Rinehart M Guix T Dugger JA Engelman CL Arteaga 2007 Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network Clin Cancer Res 13 4909 4919 10.1158/1078-0432.CCR-07-0701 1:CAS:528:DC%2BD2sXptVGmtLg%3D 17699871 (Pubitemid 47294799)
42. S Johnston M Trudeau B Kaufman H Boussen K Blackwell P LoRusso DP Lombardi S Ben Ahmed DL Citrin ML DeSilvio J Harris RE Westlund V Salazar TZ Zaks NL Spector 2008 Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy J Clin Oncol 26 1066 1072 10.1200/JCO.2007.13.9949 1:CAS:528:DC%2BD1cXktVKisbY%3D 18212337
43. CJ Proietti C Rosemblit W Beguelin MA Rivas MC Diaz Flaqué EH Charreau R Schillaci PV Elizalde 2009 Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth Mol Cell Biol 29 1249 1265 10.1128/MCB.00853-08 1:CAS:528: DC%2BD1MXitlylsr4%3D 19103753